Australia is the latest country to secure a supply of a vaccine for COVID-19 being developed by Oxford University and pharmaceutical giant AstraZeneca and is considering mandatory vaccination for travellers crossing its borders.
Prime Minister Scott Morrison on Wednesday said he had signed a deal which would make the vaccine free for the population of about 25 million.
“Under this deal we have secured early access for every Australian,” Morrison said. “If this vaccine proves successful we will manufacture and supply vaccines straight away under our own steam and make it free for 25 million Australians.”
Morrison initially said it was likely that vaccinations would be mandatory and that government policy was still being worked on. Speaking on a radio station he said the vaccine would be “as mandatory as you could possibly make it.”
“There are always exemptions for any vaccine on medical grounds, but that should be the only basis,” he said.
But he later backtracked and said he would take measures to “encourage” citizens to be vaccinated.
However travellers entering the country, including returning nationals, may have to submit to mandatory vaccinations.
Health minister Greg Hunt said he “wouldn’t rule out” making it mandatory for anyone travelling to Australia – including Australians returning to the country – if that was the advice from medical experts, according to the BBC.
The vaccine is one of five being developed which so far have the most potential and there has been a race among countries seeking to gain access. Last week Argentina and Mexico said they would make it for Latin America.
While Australia has recorded around 24,000 cases and only 438 deaths it has noted a worrying surge of new recent coronavirus infections.
The state of Victoria declared a state of disaster after a huge rise in infections recently and strict lockdown measures have been implemented. Morrison warned: “there is no guarantee that this, or any other, vaccine will be successful.”
The U.K. government has already ordered 100 million doses of the Oxford-AstraZeneca AZN, -0.30% vaccine.
Add Comment